# Inogen Inc: filings

INGN · Nasdaq · CIK 1294133 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ingn.md) · [Financials](/companies/ingn/financials.md) · [Filings](/companies/ingn/filings.md) · [Insiders](/companies/ingn/insiders.md)

## Reports and events: 217 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 574, 8-K 139, 3 44, SC 13G/A 42, 10-Q 38, S-8 16, DEFA14A 14, 10-K 13, 4/A 13, DEF 14A 12, SD 11, SC 13G 10, 8-K/A 7, CORRESP 7, UPLOAD 7, S-1/A 6, ARS 5, 144 4, CT ORDER 4, 3/A 3, SCHEDULE 13G/A 3, 424B4 2, EFFECT 2, FWP 2, S-1 2, 8-A12B 1, CERTNAS 1, D 1, D/A 1, DRS 1, NT 10-K 1, NT 10-K/A 1, PRE 14A 1, REGDEX 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-30 | 16:10 ET | [8-K](/filings/0001294133-26-000037.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001294133-26-000037 |
| 2026-08-07 | 16:11 ET | [10-Q](/filings/0001294133-26-000034.md) | Quarterly report, period 2026-06-30 | 0001294133-26-000034 |
| 2026-08-06 | 16:10 ET | [8-K](/filings/0001294133-26-000032.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001294133-26-000032 |
| 2026-07-01 | 16:09 ET | [8-K](/filings/0001294133-26-000025.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001294133-26-000025 |
| 2026-06-11 | 16:32 ET | [8-K](/filings/0001294133-26-000021.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001294133-26-000021 |
| 2026-05-08 | 16:10 ET | [10-Q](/filings/0001294133-26-000016.md) | Quarterly report, period 2026-03-31 | 0001294133-26-000016 |
| 2026-05-07 | 16:13 ET | [8-K](/filings/0001294133-26-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001294133-26-000014 |
| 2026-04-28 | 16:09 ET | [DEF 14A](/filings/0001294133-26-000009.md) | Proxy statement, period 2026-04-28 | 0001294133-26-000009 |
| 2026-04-06 | 16:02 ET | [8-K](/filings/0001193125-26-143703.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-143703 |
| 2026-03-30 | 17:32 ET | [8-K](/filings/0001193125-26-131855.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-131855 |
| 2026-02-27 | 16:12 ET | [10-K](/filings/0001193125-26-082630.md) | Annual report, period 2025-12-31 | 0001193125-26-082630 |
| 2026-02-24 | 16:06 ET | [8-K](/filings/0001193125-26-066968.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-066968 |
| 2026-01-12 | 08:41 ET | [8-K](/filings/0001193125-26-009878.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-009878 |
| 2025-11-06 | 16:08 ET | [10-Q](/filings/0001193125-25-269484.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269484 |
| 2025-11-05 | 07:36 ET | [8-K](/filings/0001193125-25-265750.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-265750 |
| 2025-08-08 | 16:11 ET | [10-Q](/filings/0000950170-25-105835.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105835 |
| 2025-08-07 | 16:24 ET | [8-K](/filings/0000950170-25-105080.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105080 |
| 2025-07-29 | 16:06 ET | [8-K](/filings/0000950170-25-099624.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-099624 |
| 2025-05-19 | 16:38 ET | [8-K](/filings/0000950170-25-074437.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-074437 |
| 2025-05-08 | 16:12 ET | [10-Q](/filings/0000950170-25-066966.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066966 |
| 2025-05-07 | 16:07 ET | [8-K](/filings/0000950170-25-065644.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-065644 |
| 2025-03-27 | 08:01 ET | [DEF 14A](/filings/0000950170-25-045737.md) | Proxy statement, period 2025-03-27 | 0000950170-25-045737 |
| 2025-02-28 | 16:05 ET | [10-K](/filings/0000950170-25-029993.md) | Annual report, period 2024-12-31 | 0000950170-25-029993 |
| 2025-02-25 | 16:06 ET | [8-K](/filings/0000950170-25-026636.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-026636 |
| 2025-02-03 | 16:22 ET | [8-K](/filings/0000950170-25-012334.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-012334 |
| 2025-01-27 | 06:03 ET | [8-K](/filings/0000950170-25-008986.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-008986 |
| 2025-01-13 | 16:06 ET | [8-K](/filings/0000950170-25-004824.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-004824 |
| 2024-12-30 | 08:35 ET | [8-K](/filings/0000950170-24-140955.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-140955 |
| 2024-11-08 | 16:19 ET | [10-Q](/filings/0000950170-24-124115.md) | Quarterly report, period 2024-09-30 | 0000950170-24-124115 |
| 2024-11-07 | 16:10 ET | [8-K](/filings/0000950170-24-123329.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123329 |
| 2024-08-07 | 16:05 ET | [10-Q](/filings/0000950170-24-092743.md) | Quarterly report, period 2024-06-30 | 0000950170-24-092743 |
| 2024-08-06 | 16:10 ET | [8-K](/filings/0000950170-24-091800.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091800 |
| 2024-07-31 | 17:05 ET | [8-K](/filings/0000950170-24-088682.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-088682 |
| 2024-07-03 | 16:15 ET | [8-K](/filings/0000950170-24-081526.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-081526 |
| 2024-06-07 | 17:20 ET | [8-K](/filings/0000950170-24-070900.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-070900 |
| 2024-05-15 | 17:10 ET | [8-K](/filings/0000950170-24-060589.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-060589 |
| 2024-05-08 | 16:06 ET | [10-Q](/filings/0000950170-24-055627.md) | Quarterly report, period 2024-03-31 | 0000950170-24-055627 |
| 2024-05-07 | 16:10 ET | [8-K](/filings/0000950170-24-054483.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-054483 |
| 2024-04-18 | 16:05 ET | [DEF 14A](/filings/0000950170-24-045541.md) | Proxy statement, period 2024-06-05 | 0000950170-24-045541 |
| 2024-04-15 | 16:15 ET | [8-K](/filings/0000950170-24-044416.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-044416 |
| 2024-03-01 | 16:01 ET | [10-K](/filings/0000950170-24-023820.md) | Annual report, period 2023-12-31 | 0000950170-24-023820 |
| 2024-02-27 | 16:08 ET | [8-K](/filings/0000950170-24-021113.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-021113 |
| 2024-01-24 | 16:05 ET | [8-K](/filings/0000950170-24-006969.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-006969 |
| 2024-01-05 | 09:00 ET | [8-K](/filings/0000950170-24-002303.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-002303 |
| 2023-11-27 | 16:00 ET | [8-K](/filings/0000950170-23-066108.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-066108 |
| 2023-11-13 | 08:35 ET | [8-K](/filings/0000950170-23-062492.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-062492 |
| 2023-11-09 | 13:33 ET | [10-Q](/filings/0000950170-23-061784.md) | Quarterly report, period 2023-09-30 | 0000950170-23-061784 |
| 2023-11-07 | 16:10 ET | [8-K](/filings/0000950170-23-060245.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-060245 |
| 2023-09-18 | 08:32 ET | [8-K](/filings/0000950170-23-048471.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-048471 |
| 2023-09-07 | 08:38 ET | [8-K](/filings/0000950170-23-046888.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-046888 |

Page 1 of 5. [Older](/companies/ingn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.